Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of L-Carnitine on Lipid-Induced Insulin Resistance
NCT02722902Terminated
- Sponsor
- Maastricht University Medical Center+
- Start
- May 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of levocarnitine in insulin resistance (IR) (3 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Whole body insulin sensitivity at 6 hours and Metabolic flexibility at 6 hours. Started May 2016; status: terminated.
02
Drugs
levocarnitine
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT02722902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02722902.